Rydex Series Trust Biotechnology Fund

Scorecard
4 / 5 Stars
Lipper
5 5 3 1 5
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
3 / 5 Stars
TheStreet.com
A- (Buy)

Fund Holdings

Asset Allocation

% Long % Short % Net
Cash 0.98 0.0 0.98
Stocks 95.34 0.0 95.34
Bonds 0.0 0.0 0.0
Other 0.0 0.13 -0.13
Foreign Bonds 0.0 0.0 0.0
Foreign Stocks 3.8 0.0 3.8
Convertible 0.0 0.0 0.0
Preferred 0.0 0.0 0.0

Updated 01.31.2014

Top 10 Holdings

Performance as of 02.28.2014

Portfolio as of 01.31.2014

Ticker YTD Return % % Net Assets
Gilead Sciences Inc GILD 8.46 7.08
Amgen Inc AMGN 8.96 6.07
Biogen Idec Inc BIIB 21.04 5.66
Celgene Corporation CELG -5.14 4.75
Alexion Pharmaceuticals, Inc. ALXN 29.76 3.77
Intercept Pharmaceuticals Inc ICPT 506.46 3.64
Regeneron Pharmaceuticals, Inc. REGN 23.35 3.48
Illumina, Inc. ILMN 56.42 3.26
Vertex Pharmaceuticals VRTX 9.77 2.73
Incyte Corp Ltd INCY 25.91 2.32